Gene Therapy Conferences
We believe the curative potential of gene therapies is enormous, particularly in the battle against rare and genetic diseases. With 350+ clinical trials active and more preclinical innovation underway, there’s a clear opportunity to offer meaningful treatments to patients with significant unmet need.
Our Gene Therapy products help you tackle the most challenging problems, from safety and quality concerns relating to dose and vector type, to manufacturing bottlenecks and navigating the evolving regulatory landscape.